Search for Clinical Trial Results
Anaplastic Oligodendroglioma - 228 Studies Found
Status | Study |
Completed |
Study Name: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma Condition:
Interventions: |
Suspended |
Study Name: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme Condition:
Interventions: |
Active, not recruiting |
Study Name: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor Condition:
|
Active, not recruiting |
Study Name: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Condition:
|
Terminated |
Study Name: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas Condition:
|
Active, not recruiting |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Condition:
Interventions: |
Completed |
Study Name: Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms Condition:
Interventions: |
Active, not recruiting |
Study Name: Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Condition:
|
Withdrawn |
Study Name: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma Condition:
|
Completed |
Study Name: Sorafenib in Newly Diagnosed High Grade Glioma Condition:
Interventions: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li |